Penn Medicine MD
@PennMDForum
We share clinical updates about the physicians and providers, research, programs and initiatives at @PennMedicine and @Penn's Perelman School of Medicine.
Join @PennMedicine on Sept. 6 for the 32nd State of the Art Arrhythmia Symposium. In-person and virtual, this course will educate participants on invasive and non-invasive EP and ECG tools used to diagnosis, evaluate and treat cardiac rhythm disorders. spr.ly/6013fKWSd

Save the Date 🗓️ The 32nd Annual State of the Art #Arrhythmia Symposium is happening in person & virtually on 9/6 in Philly. Join leaders in #electrophysiology & #cardiology for cutting-edge insights. Register👉 spr.ly/60124hLgI #EPeeps #CME
Penn Medicine bariatric surgeon Dr. Maria Altieri discusses obesity treatment options, including GLP-1 weight loss meds, and the mindset for long-term success. Essential for clinicians managing obesity and its comorbidities. spr.ly/6018fGkP0
Join oncology experts for a powerful weekend of learning and collaboration as we review top abstracts and clinical takeaways from #ASCO25. This is a unique opportunity to engage with cutting-edge research and apply it directly to practice. spr.ly/6015fBonU
Is there a surgical answer to intractable hypertension? Penn Medicine Drs. Kobayashi and Cohen discuss catheter-based renal denervation and its indications, efficacy, and precautions for eligibility for patients with refractory hypertension. spr.ly/60124Cjfo
Listen in as three pioneering investigators from the University of Pennsylvania’s Abramson Cancer Center (ACC) discuss their cutting-edge research with the ACC Community Advisory Board. spr.ly/601944kCx
Alexander W. R. Bridges, MD, a Cardiothoracic Surgeon @LGHealth, dives into advanced #Afib treatment discussing causes, risk factors, pathophysiology, & treatments like the Cox-Maze 3 procedure, left atrial appendage removal & more advances @PennCardiology spr.ly/60194lzWN
Congratulations to @johnplastaras and @michelleiocolan on your innovation award!
Celebrate our new award winners who are accelerating RT for non-cancerous conditions @carmenbergom @WashUMedRadOnc @KhashiFattah @BobTimmermanMD @UTSW_RadOnc @michelleiocolan @johnplastaras @PennRadOnc @sueyom @UCSFRadOnc More on their pioneering research bit.ly/ROI2025Innovat…
New in JLGH by @LGHealth: Drs Yan and Wray review the safety profile of GLP-1 receptor agonists, including adverse effects, contraindications, and considerations for clinical use. Essential reading as utilization expands in #obesity and #diabetes care. spr.ly/60164jnYu
Congratulations to Dr. Nancy Speck, whose research has provided critical knowledge to help us understand how certain blood cancers and other blood disorders develop. Learn more about her work: pennmedicine.org/news/nancy-spe…
ASH is proud to recognize 11 hematologists whose groundbreaking research and leadership have transformed the understanding and care of blood disorders. Congratulations to all! 👏 🔗 ow.ly/EsgX50WbEwx #Hematology #ASHAwards
Last week, Penn Aorta Center Director Dr. Desai and Vascular Director Dr. Wang hosted an Aorta Summit Dinner Meeting sharing expertise, resources, and the opportunity to collaborate in comprehensive aortic disease patient care @penncardiology @pennsurgery



In a @BCRFcure webinar, @DrLolaFayanju said that post-menopausal #BreastCancer is more likely in White women, but “more likely a Black woman will be diagnosed before they’ve begun regular screening and with a cancer that’s more biologically aggressive.” spr.ly/6013NFVeZ
🚨 Don’t miss our educational session today! 📍 E450A, 8 AM CT 🎤 @kaushalpar @BRicciutiMD @ASCO #ASCO25 @OncoAlert #LCSM
#ASCO25 @ASCO Education Book has incredible resources in #LungCancer #LCSM Super proud of an amazing team of fellows mentored by @kaushalpar @BiagioRicciutMD and me! @BenBleibergMD @tejavoruganti So much going on in this space - especially with #NeoADAURA being presented,…
ICYMI ➡️ recent @PennMedicine clinical trials found that asynchronous semiautomated referrals for pharmacist involvement in lipid management could be a scalable approach for increasing #statin prescribing. Here's why 👇 spr.ly/6015NxOuP #Pharmarceuticals #Cardiology
#ASCO25 Does neoadjuvant immunotherapy have a place in earlier-stage melanoma? Giorgos Karakousis, MD, shares the results of a Phase II study on the closing day of @ASCO. Abstract 9502. @PennMedMelanoma @PennSurgery
Congrats @StephenBagleyMD @DrORourke2 and colleagues @PennCancer on their manuscript in @NatureMedicine showing safety and early efficacy of bivalent CAR T cells in 18 patients with recurrent #glioblastoma! nature.com/articles/s4159…
#PC3IatASCO: @chefaleixomd, @ramsedhom, @efratdotan, & @ravi_b_parikh evaluating implementation of the Practical #Geriatric Assessment & resulting #chemotherapy dose modification among older adults with #cancer. #ASCO25 @ASCO meetings.asco.org/abstracts-pres… pc3i.upenn.edu/news/pc3i-pres…
Last night at the @PennCancer reception! Wonderful representation @ASCO #ASCO25 and we had with several faculty, fellows, alumni presenting science that can change practice! @PennMDForum @PennMedicine
Join us either in person or virtually for the Updates in Oncology 2025 meeting on 6/11, which will address the questions that have emerged from the latest data presented at major international annual meetings. Learn more and register here: spr.ly/6019NfiRX
#ASCO25: @StephenBagleyMD on CAR T cell for glioblastoma: “The treatment changed the trajectory of their disease.” Now in @NatureMedicine and on the @ASCO stage today. Abstract 102. @DrORourke2 spr.ly/6018N7k16